Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer.
CONCLUSION: Our study generates the hypothesis that NAC equalizes the preoperative disparity in pathologic stage between males and females suggesting a possible differential response between sexes. This might be the explanation underlying the comparable survival outcomes between sexes despite females presenting with more advanced tumor stage.
PMID: 32057595 [PubMed - as supplied by publisher]
Source: Urologic Oncology - Category: Urology & Nephrology Authors: D'Andrea D, Black PC, Zargar H, Zargar-Shoshtari K, Zehetmayer S, Fairey AS, Mertens LS, Dinney CP, Mir MC, Krabbe LM, Cookson MS, Jacobsen NE, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Campain NJ, Kassouf W, Dall'Era MA, Seah JA, Ercole CE, Horenblas S, Tags: Urol Oncol Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Men | Menopause | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Smokers | Study | Urology & Nephrology